Key facts
- Aveera Medical’s last known valuation is $17.0M (Apr 2024).
- It has raised $9.4M across 2 recorded rounds; the latest was Early Stage VC ($5.4M) in Feb 2026.
- Aveera Medical has filed 2 Form Ds with the SEC since 2024, most recently Feb 2026 ($5.4M sold to 89 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·Watchlist + deal alerts for Aveera Medical
Funding rounds
2 roundsAbout Aveera Medical
Developer of medical devices designed to prevent amputations. The company device may help restore blood flow to the foot by a procedure known as deep venous arterialization, enabling patients to avoid lower leg amputation and promote wound healing.
- Sector
- Healthcare
- HQ
- San Clemente, CA, United States
- Founded
- 2020
- Employees
- 8
- Website
- boomerangdvatrial.com/
- Ownership
- Privately Held (backing)
Aveera Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Aveera Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Aveera Medical in its N-PORT filings yet. We sweep new filings monthly.